Managing Director of Synergen Met, Chris Dunks, is interviewed by business journalist Oriel Morrison in Stockhead's podcast series, Stock Insiders.
The podcast provides an overview of Synergen Met and the company's workings within plasma technology for over 14 years. The podcast discusses how the company uses thermal plasma as a core enabler of applications that reduce harmful carbon emissions and detoxify industries.
Chris says that the future of Synergen Met "will be having significant growth here in Australia and across into the United States."
With a planned ASX listing in June 2022 under the ASX ticker code SH2, Synergen will use the funds raised to advance its hydrogen rollout strategy and build PFAS destruction facilities in Australia and the US.
Synergen Met Ltd
Synergen is an Australian-owned and operated business made up of a team of scientific minds with more than 80 years of collective experience working within the global resources industry. Founders, Christopher Dunks and Dr Geoff Duckworth, have developed the Company’s Thermal Plasma Technology over the last 14 years.
Through a combination of research, innovative ideas, trial and error in the lab, extensive field trials, and close collaboration with our key equipment supplier, the Company has developed its ability to leverage its Thermal Plasma Technology applications platform into multiple high value applications
Stock Insiders is a new podcast series powered by Stockhead focusing on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm.
To listen to the full Stock insiders podcast, click here.
